NCT01482715 A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) Status COMPLETED Phase PHASE1/PHASE2
NCT01471483 Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer Status COMPLETED Phase N/A
NCT01469793 A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer Status COMPLETED Phase PHASE1
NCT01459653 Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor Status COMPLETED Phase N/A
NCT01445418 AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer Status COMPLETED Phase PHASE1
NCT01444456 Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia Status COMPLETED Phase N/A
NCT01441089 Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis Status RECRUITING Phase N/A
NCT01440504 Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors Status COMPLETED Phase N/A
NCT01439659 Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01433224 Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression Status COMPLETED Phase N/A
NCT01432145 A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours Status COMPLETED Phase PHASE2
NCT01432015 Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting Status COMPLETED Phase PHASE4
NCT01419210 Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer Status COMPLETED Phase NA
NCT01416038 Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer Status COMPLETED Phase PHASE1
NCT01402271 Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer Status COMPLETED Phase PHASE1/PHASE2